0Suppliers
6Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

Tectonic Therapeutic, Inc. (TECX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

10Total relationships
2Distinct source URLs
5High confidence
0.795Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Tectonic Therapeutic, Inc. Suppliers

No suppliers on recordTectonic Therapeutic, Inc. does not appear to disclose named supplier relationships in its verified regulatory filings, or upstream suppliers have not yet been identified. Our system processes new filings continuously.

Tectonic Therapeutic, Inc. Customers

TickerNameConfidenceEvidence
HONG-KONG-LIMITED HONG-KONG-LIMITED 85% sely affected. Risks Related to Our Reliance on Third Parties We currently rely on and expect to rely on in the future on the use of manufacturing suites in third-party facilities or on third parties…
MYGN Myriad Genetics, Inc. 72% Reciprocal relationship from MYGN graph: Reciprocal relationship from TECX graph: Reciprocal relationship from MYGN graph: Reciprocal relationship from TECX graph: from third parties to advance our r…
MYGN Myriad Genetics, Inc. 72% from third parties to advance our research or allow commercialization of our product candidates. We may fail to obtain any of these licenses at a reasonable cost or on reasonable terms, if at all. In…
SNYNF Sanofi 72% from third parties to advance our research or allow commercialization of our product candidates. We may fail to obtain any of these licenses at a reasonable cost or on reasonable terms, if at all. In…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from TECX graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from TECX graph: Reciprocal relationship from SNYN…
CAPITAL-RESOURCES CAPITAL-RESOURCES 62% onths ended March 31, 2025 primarily due to lower cash and cash equivalents. Liquidity and Capital Resources Sources of Liquidity Since our inception, we have incurred significant operating losses. W…

Tectonic Therapeutic, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
TECX-DEBT-12931 Warrants outstanding: 197000 90% xbrl warrant detail from xbrl 2018-12-31.
TECX-DEBT-12932 Xbrl Convertible 90% xbrl convertible detail from xbrl 2018-12-31.
TECX-DEBT Debt stack $15.0M 90% Market cache reports total debt of $15.0M.

Tectonic Therapeutic, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Tectonic Therapeutic, Inc..

Tectonic Therapeutic, Inc. Ownership

HolderNameConfidenceEvidence
TECX-OWNER-FMR-LLC FMR LLC 90% 13F overlay lists FMR LLC as top holder; 114 tracked holders.

Tectonic Therapeutic, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CALC CalciMedica, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
BNTC Benitec Biopharma Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
ATOS Atossa Therapeutics, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
🔐
TECX
Unlock TECX Supply Chain Data
Verified relationships include:
HONG-KONG-LIMITEDHONG-KONG-LIMITEDCustomer85%
MYGNMyriad Genetics, Inc.Customer72%
+6 more relationships locked
Subscribe, View plans →